Antimetabolites: all 8,294 studies that test it

Page 67 of 83. Open to participants first (1,149), then studies with results posted, then the rest; newest registration first within each.

• Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
• Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesCompletedNCT00490659Phase 2
• Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract CarcinomasCompletedNCT00490399Phase 2
• Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is MetastaticCompletedNCT00490373Phase 2
• Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCompletedNCT00489996Phase 2
• Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With ChemotherapyCompletedNCT00489983Phase 2
• An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected IndividualsCompletedNCT00489385Phase 1
• Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00488709Phase 4
• H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisWithdrawnNCT00488605Phase 3
• Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerStatus unknownNCT00486460Phase 3
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
• A Trial of Hydroxyurea in Spinal Muscular AtrophyCompletedNCT00485511Phase 2/3
• Ribavirin, Its Dosing RegimeCompletedNCT00484328Phase 4
• A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00483834Phase 2
• Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00483366Phase 1
• 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)CompletedNCT00483067Phase 2
• Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and AllopurinolCompletedNCT00480883Not applicable
• Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast CancerCompletedNCT00480597Phase 2
• A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1
• A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate CancerCompletedNCT00480090Phase 2
• Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid TumorsCompletedNCT00479128Phase 1
• A Study of Picoplatin in Colorectal CancerStatus unknownNCT00478946Phase 1/2
• Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHLCompletedNCT00477945Phase 1
• Effects of Allopurinol on Diastolic Function in Chronic Heart Failure PatientsCompletedNCT00477789Phase 4
• A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00477711Phase 2
• A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCTCompletedNCT00477542Phase 1
• A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaTerminatedNCT00476554Phase 2
• A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced MalignanciesTerminatedNCT00475917Phase 1
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.CompletedNCT00475072Phase 4
• Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
• Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus SorafenibTerminatedNCT00473486Phase 1/2
• Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic BreastTerminatedNCT00473005Phase 1
• Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCompletedNCT00471965Phase 3
• Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00471484Phase 2
• Study of Methotrexate in Lupus ErythematosusCompletedNCT00470522Phase 3
• Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
• Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast CancerTerminatedNCT00470249Phase 2
• Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment RegimensCompletedNCT00470210Phase 4
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00470197Phase 1
• Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
• Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRCCompletedNCT00469443Phase 3
• PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas CaCompletedNCT00467116Phase 1
• Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver TransplantCompletedNCT00466219Phase 3
• Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade GliomaCompletedNCT00463008Not applicable
• Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00462852Phase 2
• Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00462787Phase 1
• Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsCompletedNCT00462553Phase 1
• Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic CancerCompletedNCT00460174Phase 2
• Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerTerminatedNCT00459901Phase 2
• PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid TumorsCompletedNCT00459836Phase 1
• Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
• Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary TumorWithdrawnNCT00458315Phase 2
• Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and RibavirinTerminatedNCT00456248Phase 4
• Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator ProductsCompletedNCT00455585Phase 4
• a Phase II Study in Primary Central Nervous System LymphomaStatus unknownNCT00455286Phase 2
• Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal CancerStatus unknownNCT00453323Phase 2
• Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerCompletedNCT00453167Phase 2
• Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00453115Phase 2
• RCT of CBT Combined With D-Cycloserine for Treating PTSDStatus unknownNCT00452231Phase 2/3
• Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic SyndromesCompletedNCT00451997Phase 2
• Objective Study in Rheumatoid ArthritisCompletedNCT00451971Phase 4
• Gemcitabine + Carboplatin in Breast CancerCompletedNCT00450762Phase 2
• Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnNCT00450515Phase 2
• Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT00449137Phase 1
• Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00448838Not applicable
• Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck CancerCompletedNCT00448552Phase 2
• Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric PatientsCompletedNCT00447967Phase 2
• Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid ArthritisCompletedNCT00446784Phase 1
• A Phase II Study of Maintenance With Azacitidine in MDS PatientsTerminatedNCT00446303Phase 2
• Treatment With High Dose Methotrexate in Patients With Eosinophilic FasciitisCompletedNCT00441961Not applicable
• Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsTerminatedNCT00440622Phase 3
• Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00440414Phase 3
• Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of CapecitabineStatus unknownNCT00440167Phase 3
• Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT00438737Phase 2
• Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV TherapyStatus unknownNCT00437476Phase 3
• Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00436800Phase 2
• A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic CancerCompletedNCT00436423Phase 2
• Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By SurgeryStatus unknownNCT00436267Phase 2
• Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 TumoursTerminatedNCT00434941Phase 2
• Safety of Everolimus and Pemetrexed in Lung Cancer PatientsCompletedNCT00434174Phase 1
• Alimta and Gemcitabine in Non-Small Cell Lung CancerCompletedNCT00434135Phase 2
• Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
• Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerActive, not recruitingNCT00433420Phase 3
• Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus PioglitazoneCompletedNCT00433069Phase 2
• Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIVCompletedNCT00432016Phase 1/2
• Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast CancerCompletedNCT00431106Phase 3
• Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast CancerCompletedNCT00429871Phase 3
• Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian CarcinomaCompletedNCT00429559Phase 1/2
• Gemcitabine and Dasatinib in Advanced Solid TumorsCompletedNCT00429234Phase 1
• Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal CancerCompletedNCT00427713Phase 3
• Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By SurgeryCompletedNCT00427570Phase 3
• Pemetrexed in Patients With Soft Tissue SarcomaCompletedNCT00427466Phase 2
• Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing SurgeryCompletedNCT00427310Phase 3
• To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.CompletedNCT00426608Phase 1
• Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal CancerStatus unknownNCT00425425Phase 1/2
• Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00425360Phase 3
• Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon CancerCompletedNCT00425152Phase 3
• Pemetrexed in Patients With Advanced Neuroendocrine TumorsCompletedNCT00424723Phase 2
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00423696Phase 2

← Antimetabolites overview